Item Type | Name |
Concept
|
Risk Factors
|
Concept
|
Risk
|
Concept
|
Risk Assessment
|
Academic Article
|
Magnetic resonance angiography for the nonpalpable testis: a cost and cancer risk analysis.
|
Academic Article
|
Perioperative clinical thromboembolic events after radical or partial nephrectomy.
|
Academic Article
|
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
|
Academic Article
|
Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
|
Academic Article
|
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
|
Academic Article
|
Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
|
Academic Article
|
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.
|
Academic Article
|
Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.
|
Academic Article
|
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons.
|
Academic Article
|
Re: Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. S. Baltaci, E. Suer, A. H. Haliloglu, M. I. Gokce, A. H. Elhan and Y. Beduk. J Urol 2009; 181: 128-132.
|
Academic Article
|
Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
|
Academic Article
|
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.
|
Academic Article
|
Re: Active surveillance failure for prostate cancer: does the delay in treatment increase the risk of urinary incontinence?
|
Academic Article
|
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
|
Academic Article
|
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
|
Academic Article
|
The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
|
Academic Article
|
Active surveillance for low-risk localized prostate cancer.
|
Academic Article
|
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: current concepts and controversies.
|
Academic Article
|
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
|
Academic Article
|
Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.
|
Academic Article
|
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
|
Academic Article
|
Short (= 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
|
Academic Article
|
Commentary on "African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?" Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, Schaeffer EM, Johns Hopkins University, Baltimore, MD. J Clin Oncol 2013; 31(24):2991-7. [Epub 2013 Jun 17]. doi: 10.1200/JCO.2012.47.0302.
|
Academic Article
|
Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
|
Academic Article
|
National trends in the management of low and intermediate risk prostate cancer in the United States.
|
Academic Article
|
Preoperative nuclear renal scan underestimates renal function after radical nephrectomy.
|
Academic Article
|
The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
|
Academic Article
|
Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
|
Academic Article
|
Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.
|
Academic Article
|
Population based analysis of incidence and predictors of open conversion during minimally invasive radical prostatectomy.
|
Academic Article
|
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
|
Academic Article
|
Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance.
|
Academic Article
|
The impact of body mass index on renal functional outcomes following minimally invasive partial nephrectomy.
|
Academic Article
|
Corneal abrasion in hysterectomy and prostatectomy: role of laparoscopic and robotic assistance.
|
Academic Article
|
Management of Low-Stage Testicular Seminoma.
|
Academic Article
|
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
|
Academic Article
|
Gleason 6 Prostate Cancer: Translating Biology into Population Health.
|
Academic Article
|
Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.
|
Academic Article
|
National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management Decisions.
|
Academic Article
|
The Impact of Perioperative Aspirin on Bleeding Complications Following Robotic Partial Nephrectomy.
|
Academic Article
|
Risk of lymph node metastases in pathological gleason score=6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
|
Academic Article
|
Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database.
|
Academic Article
|
Low-risk Prostate Cancer: Identification, Management, and Outcomes.
|
Academic Article
|
Contemporary management of men with high-risk localized prostate cancer in the United States.
|
Academic Article
|
Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
|
Academic Article
|
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.
|
Academic Article
|
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
|
Academic Article
|
Contemporary management of men with high-risk localized prostate cancer in the United States.
|
Academic Article
|
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
|
Academic Article
|
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review.
|
Academic Article
|
A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.
|
Academic Article
|
Re: Use of Active Surveillance or Watchful Waiting for Low-risk Prostate Cancer and Management Trends Across Risk Groups in the United States 2010-2015.
|
Academic Article
|
Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study.
|
Academic Article
|
Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy.
|
Academic Article
|
Incidence, Risk Factors, and Outcomes for Rectal Injury During Radical Prostatectomy: A Population-based Study.
|
Academic Article
|
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging.
|
Academic Article
|
Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer.
|
Academic Article
|
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.
|
Academic Article
|
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
|
Academic Article
|
Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors.
|
Academic Article
|
Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
|
Academic Article
|
Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
|
Academic Article
|
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
|
Academic Article
|
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
|
Academic Article
|
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
|
Academic Article
|
Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance.
|
Academic Article
|
Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen.
|
Academic Article
|
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
|
Academic Article
|
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
|
Academic Article
|
Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2-4 Prostate Cancer.
|